Yesterday it was reported that a Director at Masimo (MASI), Steven Barker, exercised options to buy 1,304 MASI shares at $240.19 a share, for a total transaction value of $313.2K.
Following Steven Barker’s last MASI Buy transaction on June 03, 2019, the stock climbed by 107.8%. In addition to Steven Barker, 6 other MASI executives reported Buy trades in the last month.
See today’s analyst top recommended stocks >>
Based on Masimo’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $270 million and quarterly net profit of $64.46 million. In comparison, last year the company earned revenue of $232 million and had a net profit of $49.32 million. The company has a one-year high of $258.00 and a one-year low of $128.36. Currently, Masimo has an average volume of 698.78K.
Based on 4 analyst ratings, the analyst consensus is Moderate Buy with an average price target of $245.00, reflecting a -3.7% downside.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Masimo Corp. is a medical technology company, which develops, manufactures and markets non invasive patient monitoring technologies, medical devices and sensors. Its products include continuous monitors, patient-worn monitors, hospital automation connectivity, capnography & gas, data download & analytics and sensors & accessories. The company was founded by Joe E. Kiani in May 1989 and is headquartered in Irvine, CA.
